Rein Therapeutics Inc.

Rein Therapeutics Inc.verified

RNTX

Price:

$1.39

Market Cap:

$36.54M

Rein Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of a novel class of therapeutics for the treatment of cancer and other diseases. It focuses on its lead product candidate, ALRN-6924, which is a cell-permeating peptide that disrupts the interaction of p53 suppressors MDM2 and MDMX with tumor suppressor p53 to reactivate tumor suppression in non-mutant, or wild-type, p53 cancers. The company was founded by Gregory L. Verdine, Rosana Kapeller, Huw M. Nash, Joseph A. Yanchik III, and Loren David Walensky on August 6, 2001 and is headquartered in Austin, TX.

Industry

Medical - Pharmaceuticals

IPO Date

2017-06-29

Stock Exchange

NASDAQ

Ticker

RNTX

The ROE as of December 2025 (TTM) for Rein Therapeutics Inc. (RNTX) is -217.16%

According to Rein Therapeutics Inc.’s latest financial reports and current stock price. The company's current ROE is -217.16%. This represents a change of 103.39% compared to the average of -106.77% of the last 4 quarters.

Rein Therapeutics Inc. (RNTX) Historical ROE (quarterly & annually)

How has RNTX ROE performed in the past?

The mean historical ROE of Rein Therapeutics Inc. over the last ten years is -11.62%. The current -217.16% ROE has changed 1.77% with respect to the historical average. Over the past ten years (40 quarters), RNTX's ROE was at its highest in in the March 2016 quarter at 0%. The ROE was at its lowest in in the June 2025 quarter at -226.80%.

Quarterly (TTM)
Annual

Average

-11.62%

Median

-0.03%

Minimum

-115.61%

Maximum

0%

Rein Therapeutics Inc. (RNTX) ROE by Quarter and Year

Discovering the peaks and valleys of Rein Therapeutics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual ROE = 0%

Minimum Annual Increase = 0%

Minimum Annual ROE = -115.61%

Quarterly (TTM)
Annual
YearROEChange
2024-115.61%50.51%
2023-0.23%55.66%
2022-0.15%146.25%
2021-0.06%-65.74%
2020-0.17%-Infinity%
20190%0%
20180%0%
20170%0%
20160%0%

Rein Therapeutics Inc. (RNTX) Average ROE

How has RNTX ROE performed in the past?

The current ROE of Rein Therapeutics Inc. (RNTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-38.66%

5-year avg

-23.24%

10-year avg

-11.62%

Rein Therapeutics Inc. (RNTX) ROE vs. Peers

How is RNTX’s ROE compared to its peers?

Rein Therapeutics Inc.’s ROE is greater than Inotiv, Inc. (-54.86%), greater than HeartBeam, Inc. (-598.94%), less than 111, Inc. (11.40%), greater than Tempest Therapeutics, Inc. (-334.76%), less than BioAtla, Inc. (590.04%), greater than Kezar Life Sciences, Inc. (-63.52%), less than Celularity Inc. (763.31%), greater than Actinium Pharmaceuticals, Inc. (-151.67%), less than Mersana Therapeutics, Inc. (183.15%), greater than Quantum BioPharma Ltd. (-289.99%),

Build a custom stock screener for Rein Therapeutics Inc. (RNTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rein Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Rein Therapeutics Inc. (RNTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Rein Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Rein Therapeutics Inc.'s ROE?

How is the ROE calculated for Rein Therapeutics Inc. (RNTX)?

What is the highest ROE for Rein Therapeutics Inc. (RNTX)?

What is the 3-year average ROE for Rein Therapeutics Inc. (RNTX)?

What is the 5-year average ROE for Rein Therapeutics Inc. (RNTX)?

How does the current ROE for Rein Therapeutics Inc. (RNTX) compare to its historical average?